Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Maves vs Remote Pharmacy

Maves
Graded #91

Higher grade

vs+1.6999999999999886
Remote Pharmacy
Graded #117

Lower grade

The verdict

Maves takes it — 71.6/100 to 69.9/100, but only just.

Maves grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Maves, operating under parent company Homera Health, is a performance-framed telehealth platform offering compounded semaglutide and tirzepatide for weight loss plus sermorelin for anti-aging, with… Remote Pharmacy is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +7
83
76
Dose & formulationRemote Pharmacy +18
65
83
Clinical oversightMaves +10
76
66
Labs & monitoringEven
52
52
FulfillmentMaves +17
87
70
Contract termsRemote Pharmacy +6
55
61
Maves · left barRemote Pharmacy · right bar

The numbers

MetricMavesRemote Pharmacy
WeighScore71.6/10069.9/100
GradeCC
Scorecard rank#91#117
Semaglutide$99/mo (starting dose, first-month rate, compounded)$167/mo (all doses, compounded)
TirzepatideNot disclosed$230/mo (all doses, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Maves

Graded #91 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed
Remote Pharmacy

Graded #117 · C

Strengths

  • Low cash-pay pricing with no subscription or hidden fees
  • Free doctor consultation and free shipping (you pay only for medication)
  • Offers injectable and sublingual or tablet forms of both drugs
  • Medication made by 503A-certified compounding facilities

Where it loses points

  • Does not publicly name its specific compounding pharmacies or clinical provider
  • Covered states are not listed on the pages reviewed
  • Newer brand with limited third-party track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard